Related references
Note: Only part of the references are listed.Thermodynamic, kinetic, and structural parameterization of human carbonic anhydrase interactions toward enhanced inhibitor design
Vaida Linkuviene et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2018)
Virtual screening and biophysical studies lead to HSP90 inhibitors
Renjie Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future
Daniel T. Gewirth
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins
Dima Kozakov et al.
NATURE PROTOCOLS (2015)
Lessons from Hot Spot Analysis for Fragment-Basec Drug Discovery
David R. Hall et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series
Tony Taldone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2
Pallav D. Patel et al.
NATURE CHEMICAL BIOLOGY (2013)
Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90
Joerg Bussenius et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms
Asta Zubriene et al.
BIOPHYSICAL CHEMISTRY (2010)
Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency
Christopher W. Murray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Thermodynamic parameters for the association of fluorinated benzenesulfonamides with bovine carbonic anhydrase II
Vijay M. Krishnamurthy et al.
CHEMISTRY-AN ASIAN JOURNAL (2007)
Fragment-based drug discovery
DA Erlanson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
GHKL, an emergent ATPase/kinase superfamily
R Dutta et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Share Paper
